LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $236,000 | -32.0% | 100,000 | 0.0% | 0.05% | -42.5% |
| Q4 2022 | $347,000 | -52.7% | 100,000 | 0.0% | 0.08% | -52.4% |
| Q3 2022 | $733,000 | +12.4% | 100,000 | 0.0% | 0.17% | +10.5% |
| Q2 2022 | $652,000 | +29.1% | 100,000 | 0.0% | 0.15% | +22.6% |
| Q1 2022 | $505,000 | -34.8% | 100,000 | 0.0% | 0.12% | -34.4% |
| Q4 2021 | $774,000 | -47.7% | 100,000 | 0.0% | 0.19% | -59.7% |
| Q3 2021 | $1,480,000 | -8.9% | 100,000 | 0.0% | 0.47% | -15.8% |
| Q2 2021 | $1,624,000 | – | 100,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |